Literature DB >> 7131703

Primary immunization with tetanus and diphtheria toxoids. Reaction rates and immunogenicity in older children and adults.

M G Myers, C W Beckman, R A Vosdingh, W A Hankins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7131703

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation.

Authors:  Hiroto Inaba; Christine M Hartford; Deqing Pei; Meredith J Posner; Jie Yang; Randall T Hayden; Ashok Srinivasan; Brandon M Triplett; Jon A McCulllers; Ching-Hon Pui; Wing Leung
Journal:  Br J Haematol       Date:  2011-10-24       Impact factor: 6.998

2.  Incidence of adverse reactions after administration of high dose diphtheria with tetanus vaccine to school leavers: retrospective questionnaire study.

Authors:  P D Sidebotham; S W Lenton
Journal:  BMJ       Date:  1996-08-31

3.  Diphtheria: epidemiological update and review of prevention and control strategies.

Authors:  E Prospero; M Raffo; M Bagnoli; R Appignanesi; M M D'Errico
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

4.  [Tetanus vaccination--tolerance and prevention of side effects].

Authors:  G Korger; U Quast; G Dechert
Journal:  Klin Wochenschr       Date:  1986-09-01

5.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

6.  An audit of adult tetanus immunity.

Authors:  S Smith
Journal:  Can Fam Physician       Date:  1989-04       Impact factor: 3.275

7.  Evaluation of the safety and pharmacokinetic profile of a new, pasteurized, human tetanus immunoglobulin administered as sham, postexposure prophylaxis of tetanus.

Authors:  R Forrat; R Dumas; M Seiberling; M Merz; C Lutsch; J Lang
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

8.  Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnel.

Authors:  Darrell E Singer; Rachel Schneerson; Christian T Bautista; Mark V Rubertone; John B Robbins; David N Taylor
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

9.  A pilot clinical trial of a recombinant ricin vaccine in normal humans.

Authors:  Ellen S Vitetta; Joan E Smallshaw; Elaine Coleman; Hasan Jafri; Callie Foster; Robert Munford; John Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

10.  Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus.

Authors:  Zuzana Biesova; Mark A Miller; Rachel Schneerson; Joseph Shiloach; Kim Y Green; John B Robbins; Jerry M Keith
Journal:  Vaccine       Date:  2009-08-15       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.